Janus International director granted 665 RSUs

Janus International Group, Inc. director Eileen M. Youds reported an equity award of 665 shares of common stock on March 11, 2026.

Rhea-AI Filing Summary

Janus International Group, Inc. director Eileen M. Youds reported an equity award of 665 shares of common stock on March 11, 2026. The award was granted at no cash cost to her as a grant or other acquisition.

According to a footnote, this grant relates to her appointment as chair of the Board’s new Innovation and Technology Committee. She received restricted stock units (RSUs) based on the closing share price on the grant date. These RSUs will fully vest on June 9, 2026, if she continues serving on the Board, and will then be settled in common shares. After this transaction, she directly holds 38,379 shares, and a footnote states her holdings include 21,866 RSUs.

Insider Trade Summary

Grant/Award: 665 shares

Grant/Award 1 txn

Insider Youds Eileen M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	665	$0.00	$0.00

Holdings After Transaction: Common Stock — 38,379 shares (Direct)

Footnotes (2)

1. F1. In connection with her appointment as chair of the Issuer's newly established Innovation and Technology Committee of the Board of Directors, the Reporting Person received restricted stock units ("RSUs") on March 11, 2026 (the "Grant Date") based on the closing price per share of the Issuer's common stock on the Grant Date. The RSUs will fully vest on June 9, 2026, subject to continued service on the Board of Directors, and will be settled by delivery of shares of the Issuer's common stock.
2. F2. Includes 21,866 RSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Eileen M. Youds report at Janus International Group (JBI)?

Eileen M. Youds reported receiving 665 shares of Janus International common stock as an equity grant. The award was recorded at a price of $0.00 per share, indicating a compensation grant rather than an open-market purchase.

Why did Eileen M. Youds receive restricted stock units from Janus International Group (JBI)?

She received restricted stock units in connection with her appointment as chair of Janus International’s newly established Innovation and Technology Committee. The grant reflects compensation for this Board leadership role rather than a discretionary share purchase in the market.

When do Eileen M. Youds’s Janus International (JBI) RSUs vest and settle?

The RSUs granted to Eileen M. Youds will fully vest on June 9, 2026, subject to her continued service on the Board. Once vested, they will be settled by delivering shares of Janus International’s common stock to her.

How many Janus International (JBI) shares does Eileen M. Youds hold after this Form 4 transaction?

Following the reported grant, Eileen M. Youds directly holds 38,379 shares of Janus International common stock. A related footnote also states that her holdings include 21,866 restricted stock units, which represent additional equity-based compensation.

Was Eileen M. Youds’s Janus International (JBI) equity grant an open-market purchase?

No. The filing identifies the transaction with code “A” as a grant, award, or other acquisition at $0.00 per share. This indicates a compensation-related stock award, not an open-market purchase of Janus International shares by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 08:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Youds Eileen M

(Last) (First) (Middle)

C/O JANUS INTERNATIONAL GROUP, INC.

135 JANUS INTERNATIONAL BLVD.

(Street)

TEMPLE GA 30179

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Janus International Group, Inc. [ JBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		A		665(1)	A	$0	38,379(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. In connection with her appointment as chair of the Issuer's newly established Innovation and Technology Committee of the Board of Directors, the Reporting Person received restricted stock units ("RSUs") on March 11, 2026 (the "Grant Date") based on the closing price per share of the Issuer's common stock on the Grant Date. The RSUs will fully vest on June 9, 2026, subject to continued service on the Board of Directors, and will be settled by delivery of shares of the Issuer's common stock.

2. Includes 21,866 RSUs.

	/s/ Elliot Kahler, as attorney-in-fact for Eileen M. Youds	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.